| abstract |
The present invention relates to (a) compounds that inhibit HCV and their salts; (b) intermediates useful in preparing the compounds and salts; (c) compositions comprising the compounds and salts; Methods for preparing the body, compounds, salts and compositions; (e) methods of using the compounds, salts and compositions; and (f) kits comprising the compounds, salts and compositions. |